Biliary Atresia Study in Infants and Children

Last updated: May 19, 2025
Sponsor: Arbor Research Collaborative for Health
Overall Status: Active - Recruiting

Phase

N/A

Condition

Gall Bladder Disorders

Treatment

N/A

Clinical Study ID

NCT00345553
BASIC Study - ChiLDReN Network
U01DK103135
U01DK062470
U01DK062436
U01DK062481
U01DK084538
U01DK062500
U01DK062497
U01DK103140
U01DK062503
U01DK103149
U01DK062456
U01DK062453
U01DK084575
U01DK062445
U01DK062452
U01DK084536
U01DK062466
  • Ages 6-20
  • All Genders

Study Summary

Little is known about the factors that cause biliary atresia nor the factors that influence disease progression. The purpose of this study is to collect the pertinent clinical information, genetic material and body fluid samples to enable investigators to address the following aims: To identify the gene or genes implicated in the etiology of BA; To identify polymorphisms that may be important in disease progression such as HLA polymorphisms; To characterize the natural history of the older, non-transplanted child with BA.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  1. Participants need to have a confirmed diagnosis of BA determined by chart reviewincluding review of pertinent diagnostic biopsy reports, radiologic reports andsurgical reports (if surgery was performed).

  2. Participants need to be >6 months of age up to and equal to the age of 20 (participants enrolled at 20 years of age will have one visit).

  3. Participants either have their native liver or have a confirmed livertransplantation.

  4. Parent, guardian or participant (if 18 years of age or older) is willing to provideinformed consent and, when appropriate, the participant is willing to assent.

Exclusion

Exclusion Criteria:

  1. Currently participating in the ChiLDReN study PROBE

  2. Inability to confirm original diagnostic evaluation of biliary atresia

  3. Inability or unwillingness of family or participant to participate in all scheduledvisits.

Study Design

Total Participants: 1265
Study Start date:
May 16, 2006
Estimated Completion Date:
May 31, 2029

Study Description

Little is known about the factors that cause biliary atresia nor the factors that influence disease progression. A variety of genetic, autoimmune and environmental influences have been hypothesized to be important. Most studies to date have focused on the neonate and young child with BA, yet the older surviving child with BA can provide important information about genetics, as well as, natural history.

The purpose of this study is to collect the pertinent clinical information, genetic material and body fluid samples to enable investigators to address the following hypotheses:

Hypothesis 1: A genetic defect is a likely causative factor for BA among children with BA and multiple congenital anomalies.

Hypothesis 2: Autoimmune factors are likely to contribute to disease progression or acquisition and can be identified by correlating HLA among children with BA to healthy controls and by comparison of those who develop early complications including, variceal bleed, ascites, and growth failure compared to those who do not.

Hypothesis 3a: Sentinel events such as variceal bleeding, ascites and growth failure are earlier predictors of death or need for liver transplantation than the pediatric end-stage liver disease score (PELD).

Hypothesis 3b: Health related quality of life will be impaired compared to healthy age matched children and relate to severity of illness.

Hypothesis 3c: Growth failure as measured by anthropometrics and nutritional supplementation will be predictive of onset of sentinel events (ascites, variceal bleed, death, and transplant) in the following 24 months.

This study will be performed by the Childhood Liver Disease Research Network (ChiLDReN), a National Institute of Diabetes & Digestive and Kidney Diseases (NIDDK) funded network.

Connect with a study center

  • Hospital for Sick Children

    Toronto, Ontario M5G 1X8
    Canada

    Active - Recruiting

  • Children's Hospital of Los Angeles

    Los Angeles, California 90027
    United States

    Active - Recruiting

  • University of California at San Francisco

    San Francisco, California 94143
    United States

    Site Not Available

  • Children's Hospital Colorado

    Aurora, Colorado 80045
    United States

    Active - Recruiting

  • The Children's Hospital

    Denver, Colorado 80218
    United States

    Site Not Available

  • Children's Healthcare of Atlanta - Emory University

    Atlanta, Georgia 30322
    United States

    Active - Recruiting

  • Ann & Robert H. Lurie Children's Hospital of Chicago

    Chicago, Illinois 60614
    United States

    Active - Recruiting

  • Riley Children's Hospital

    Indianapolis, Indiana 46202
    United States

    Active - Recruiting

  • Johns Hopkins School of Medicine

    Baltimore, Maryland 21287
    United States

    Completed

  • Washington University School of Medicine

    Saint Louis, Missouri 63110
    United States

    Site Not Available

  • Washington University School of Medicine

    St Louis, Missouri 63110
    United States

    Completed

  • Mount Sinai Medical Center

    New York, New York 10029
    United States

    Completed

  • Children's Hospital Medical Center

    Cincinnati, Ohio 45229
    United States

    Active - Recruiting

  • Children's Hospital of Philadelphia

    Philadelphia, Pennsylvania 19104
    United States

    Active - Recruiting

  • UPMC Children's Hospital of Pittsburgh

    Pittsburgh, Pennsylvania 15224
    United States

    Active - Recruiting

  • Texas Children's Hospital (Baylor College of Medicine)

    Houston, Texas 77030
    United States

    Active - Recruiting

  • University of Utah

    Salt Lake City, Utah 84113
    United States

    Active - Recruiting

  • Seattle Children's Hospital

    Seattle, Washington 98105
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.